Activation of a Novel Ataxia-telangiectasia Mutated and Rad3 Related/checkpoint Kinase 1-dependent Prometaphase Checkpoint in Cancer Cells by Diallyl Trisulfide, a Promising Cancer Chemopreventive Constituent of Processed Garlic
Overview
Affiliations
Diallyl trisulfide (DATS), a cancer chemopreventive constituent of garlic, inhibits growth of cancer cells by interfering with cell cycle progression, but the mechanism is not fully understood. Here, we show the existence of a novel ataxia-telangiectasia mutated and Rad3 related (ATR)/checkpoint kinase 1 (Chk1)-dependent checkpoint partially responsible for DATS-mediated prometaphase arrest in cancer cells, which is different from the recently described gamma irradiation-induced mitotic exit checkpoint. The PC-3 human prostate cancer cells synchronized in prometaphase by nocodazole treatment and released to DATS-containing medium remained arrested in prometaphase, whereas the cells released to normal medium exited mitosis and resumed cell cycle. The mitotic arrest was maintained even after 4 h of culture of DATS-treated cells (4-h treatment) in drug-free medium. The DATS-arrested mitotic cells exhibited accumulation of anaphase-promoting complex/cyclosome (APC/C) substrates cyclin A and cyclin B1 and hyperphosphorylation of securin, which was accompanied by increased phosphorylation of the APC/C regulatory subunits Cdc20 and Cdh1. The DATS-mediated accumulation of cyclin B1 and hyperphosphorylation of securin, Cdc20, and Cdh1 were partially but markedly attenuated by knockdown of Chk1 or ATR protein. The U2OS osteosarcoma cells expressing doxycycline-inducible kinase dead ATR were significantly more resistant not only to DATS-mediated prometaphase arrest but also to the accumulation of cyclin B1 and hyperphosphorylation of securin, Cdc20, and Cdh1 compared with cells expressing wild-type ATR. However, securin protein knockdown failed to rescue cells from DATS-induced prometaphase arrest. In conclusion, the present study describes a novel signaling pathway involving ATR/Chk1 in the regulation of DATS-induced prometaphase arrest.
Kanga K, Kanga L, Mendonca P, Soliman K, Ferguson D, Reed S Anticancer Res. 2023; 43(6):2393-2405.
PMID: 37247921 PMC: 10791149. DOI: 10.21873/anticanres.16407.
Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies.
Livingstone T, Beasy G, Mills R, Plumb J, Needs P, Mithen R Nutrients. 2019; 11(9).
PMID: 31540470 PMC: 6769996. DOI: 10.3390/nu11092245.
Association of ATM and BMI-1 genetic variation with breast cancer risk in Han Chinese.
Yue L, Wang F, Zhang M, Liu D, Chen P, Mei Q J Cell Mol Med. 2018; 22(7):3671-3678.
PMID: 29691986 PMC: 6010860. DOI: 10.1111/jcmm.13650.
Zheng L, Zhu Y, Lei L, Sun W, Cheng G, Yang S Oncol Lett. 2018; 15(1):568-574.
PMID: 29391889 PMC: 5769388. DOI: 10.3892/ol.2017.7344.
Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment.
Puccinelli M, Stan S Int J Mol Sci. 2017; 18(8).
PMID: 28788092 PMC: 5578035. DOI: 10.3390/ijms18081645.